Definition:
The Cold and Cough market encompasses a range of over-the-counter (OTC) products sold through pharmacies. These products include both natural and synthetic agents designed to alleviate symptoms related to cough, cold, sore throat, expectorants, and flu-like infections. The market includes various forms of medication such as pills, syrups, lozenges, sprays, ointments, and granulates for both external and internal usage. However, the market excludes prescription medicines, products contrary to state regulations, or those not explicitly designed for cold or cough relief, such as painkillers. Some of the leading products in this market include nose sprays, Mucosolvan syrup, Grippostad C, Sinupret forte, Gelomyrtol, Dolo-Dobendan, Aspirin Complex, Bepanthen nose and eye cream, ACC Akut, Neo-Angin, Vick Vaporup, and Isla Moos. This market exclusively covers product sales through pharmacies.
Additional Information:
The Cold and Cough market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.
Notes: Data was converted from local currencies using average exchange rates of the respective year.
Most recent update: Jun 2024
Source: Statista Market Insights
Most recent update: Jun 2024
Source: Statista Market Insights
Most recent update: Jun 2024
Source: Statista Market Insights
The Cold & Cough Remedies (Pharmacies) market in Dominican Republic is experiencing significant growth and development.
Customer preferences: In the Dominican Republic, customers have a strong preference for over-the-counter cold and cough remedies that are easily accessible and affordable. They value convenience and seek products that provide quick relief from symptoms such as coughing, congestion, and sore throat. Customers also prefer remedies that are safe and have minimal side effects.
Trends in the market: One of the key trends in the Cold & Cough Remedies market in Dominican Republic is the increasing demand for natural and herbal remedies. Customers are becoming more health-conscious and are seeking products that are perceived as more natural and less chemically-based. This trend is driven by a growing awareness of the potential side effects of traditional pharmaceutical remedies and a desire for more holistic approaches to healthcare. Another trend in the market is the rising popularity of combination products. Customers prefer remedies that offer multiple benefits, such as relieving both cold and cough symptoms. Combination products that include ingredients like antihistamines, decongestants, and pain relievers are in high demand as they provide comprehensive relief from multiple symptoms.
Local special circumstances: The Dominican Republic has a tropical climate, which makes it prone to seasonal changes and fluctuations in temperature. These weather conditions contribute to the prevalence of cold and cough infections, leading to a higher demand for remedies in the market. Additionally, the country has a high population density, which increases the risk of contagious diseases spreading quickly. This further drives the need for effective cold and cough remedies.
Underlying macroeconomic factors: The growing population and increasing disposable income in the Dominican Republic are key macroeconomic factors driving the development of the Cold & Cough Remedies market. As the population continues to grow, the demand for remedies to alleviate cold and cough symptoms is expected to increase. Moreover, rising disposable income allows consumers to afford healthcare products, including over-the-counter remedies. This, in turn, fuels the growth of the market. In conclusion, the Cold & Cough Remedies (Pharmacies) market in Dominican Republic is developing due to customer preferences for accessible and affordable remedies, the increasing demand for natural and combination products, local special circumstances such as the tropical climate and high population density, as well as underlying macroeconomic factors like population growth and rising disposable income.
Most recent update: Jun 2024
Source: Statista Market Insights
Data coverage:
The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.Modeling approach:
Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.Additional notes:
The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.